טוען...
Targeting AKT for cancer therapy
INTRODUCTION: Targeted therapies in cancer aim to inhibit specific molecular targets responsible for enhanced tumor growth. AKT/PKB (protein kinase B) is a serine threonine kinase involved in several critical cellular pathways including survival, proliferation, invasion, apoptosis, and angiogenesis....
שמור ב:
| הוצא לאור ב: | Expert Opin Investig Drugs |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6901085/ https://ncbi.nlm.nih.gov/pubmed/31594388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2019.1676726 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|